Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alumis Inc. (ALMS) Market Cap & Valuation Ratios

Alumis Inc. (ALMS) has a market cap of $877.6M and a price-to-sales ratio of 118.6, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALMSAlumis Inc.Follow ALMS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
877.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
ALMS0.9—110.0————-127%
GLUE0.9—29.1—-3.5%-84%—-61%
CGEM0.9——————-67%
VSTM0.9—9.7——+3996%-183%—
RIGL0.9—3.09.48.8%+3%31%17%
CRVS0.9———-5.1%——-42%
MGTX0.911.02.14.31.2%+948%46%165%
AKTS0.9———————
SVRA0.9———-12.8%——-109%
ANRO0.9———-8.0%———
KURA0.9—4.5—-13.7%+25%-412%—
Median of these 1011.04.56.8-5.1%+25%-76%-51%

; EV/Sales 110.0 vs. 4.5.

Growth vs. price

each dot a company · hover or tap for values

Alumis Inc. — questions

What is Alumis Inc.'s market cap?
$877.6M.
What is Alumis Inc.'s price-to-sales ratio?
118.6.

Every figure on this page comes from Alumis Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.